January is Cervical Cancer Awareness Month. It’s a time to celebrate progress against a disease that was once a leading cause of cancer-related death among U.S. women.Read More
Understanding the identity of the factors that increase risk for a particular type of cancer is vital for developing and implementing effective clinical and public health initiatives to reduce incidence and mortality of that type of cancer.Read More
In examination rooms all around the country, a big decision turns on a single moment.
A pediatrician tells a parent that his or her adolescent should be vaccinated against the human …
The AACR strongly aligns with all 69 National Cancer Institute (NCI)-designated centers, which jointly issued a call to action last week urging parents and providers to more diligently ensure all …Read More
Cancer awareness months provide an opportunity to increase public knowledge of all aspects of a particular cancer, from prevention, to treatment, to issues surrounding survivorship. This month is Cervical Cancer …Read More
Last week, the U.S. Food and Drug Administration (FDA) announced the approval of a new vaccine—Gardasil 9—that prevents infection with five more cancer-causing subtypes of human papillomavirus (HPV) than the …Read More
A nine-valent HPV vaccine currently under FDA review may prevent nearly 90 percent of cervical cancers worldwide, but we have some setbacks with getting our kids vaccinated.Read More